Federal Register / Vol. 81, No. 27 / Wednesday, February 10, 2016 / Notices 7123 

(9) Are there biological indices or 

metrics that should be used to aid in the 

interpretation of biomonitoring data for 

1–BP? What is the most appropriate 

biomarker that can confirm and quantify 

occupational exposures to 1–BP? 

(10) Should acute exposure 

recommendations, such as a short term 

exposure limit (STEL), be derived for 1– 

BP? If so, what data support the 

development of the STEL? 

(11) NIOSH provided Globally 

Harmonized System (GHS) of 

Classification and Labelling of 

Chemicals designations for health 

endpoints evaluated in the criteria 

document. Please comment on the 

utility of these classifications for hazard 

communication. Are these 

classifications helpful for employers? 

II. Public Meeting 

NIOSH will hold a public meeting on 

the draft document Criteria for a 

Recommended Standard: Occupational 

Exposure to 1-Bromopropane (1–BP) to 

allow commenters to provide oral 

comments on the draft document, to 

inform NIOSH about additional relevant 

data or information, and to ask 

questions on the draft document and 

NIOSH recommendations. 

This meeting is open to the public. 

Attendance is limited only by the space 

available. The meeting room 

accommodates 100 people. The meeting 

will be open to a limited number of 

participants through a conference call 

phone number and Webcast live on the 

Internet. 

Notification of intent to attend the 

meeting, for in-person and remote 

participation, must be made to the 

NIOSH Docket Office, at nioshdocket@

cdc.gov, (513) 533–8611, no later than 

March 16, 2016. Priority for attendance 

will be given to those providing oral 

comments. Other requests to attend the 

meeting will then be accommodated on 

a first-come, first-served basis. 

Registration is required for in-person 

attendance and remote participation. 

Because this meeting is being held at a 

federal site, pre-registration is required 

on or before March 16, 2016 and a 

government-issued photo ID (driver’s 

license, military ID or passport) will be 

required to obtain entrance to the 

facility. There will be an airport-type 

security check. Non-US citizens need to 

register by February 24, 2016 to allow 

sufficient time for mandatory facility 

security clearance procedures to be 

completed. This information will be 

transmitted to the CDC Security Office 

for approval. An email confirming 

registration will be sent from NIOSH for 

both in-person participation and audio 

conferencing participation. 

Oral comments will be permitted for 

15 minutes. If additional time becomes 

available, presenters will be notified. 

All requests to present should contain 

the name, address, telephone number, 

and relevant business affiliations of the 

presenter, topic of the presentation, 

whether you will be presenting in 

person or by phone, and the 

approximate time requested for the 

presentation. An email confirming 

registration will be sent from the NIOSH 

Docket Office and will include details 

needed to participate. Oral comments 

given at the meeting will be recorded 

and included in the docket. 

After reviewing the requests for 

presentations, NIOSH will notify the 

presenter when his/her presentation is 

scheduled. If a participant is not in 

attendance when his/her presentation is 

scheduled to begin, the remaining 

participants will be heard in order. After 

the last scheduled speaker is heard, 

participants who missed their assigned 

times may be allowed to speak, limited 

by time available. 

Attendees who wish to speak but did 

not submit a request for the opportunity 

to make a presentation may be given 

this opportunity after the scheduled 

speakers are heard, at the discretion of 

the presiding officer and limited by time 

available. 

You may submit comments, identified 

by CDC 2016–0003 and NIOSH 057–A, 

by either of the following methods: 

• Federal eRulemaking Portal: 

www.regulations.gov. Follow the 

instructions for submitting comments. 

• Mail: National Institute for 

Occupational Safety and Health, NIOSH 

Docket Office, 1090 Tusculum Avenue, 

MS C–34, Cincinnati, Ohio 45226–1998. 

Instructions: All information received 

in response to this notice must include 

the agency name and docket number 

[CDC–2016–0003; NIOSH 057–A]. All 

relevant comments received will be 

posted without change to 

www.regulations.gov including any 

personal information provided. All 

information will be available for public 

examination and copying at the NIOSH 

Docket Office, 1150 Tusculum Avenue, 

Room 155, Cincinnati, Ohio 45226. 

Non-U.S. Citizens: Because of CDC 

Security Regulations, any non-U.S. 

citizen wishing to attend this meeting 

must provide the following information 

in writing to the NIOSH Docket Officer 

at the address below no later than 

February 24, 2016. 

Name: 

Gender: 

Date of Birth: 

Place of Birth (city, province, state, country): 

Citizenship: 

Passport Number: 

Date of Passport Issue: 

Date of Passport Expiration: 

Type of Visa: 

U.S. Naturalization Number (if a naturalized 

citizen): 

U.S. Naturalization Date (if a naturalized 

citizen): 

Visitor’s Organization: 

Organization Address: 

Organization Telephone Number: 

Visitor’s Position/Title within the 

Organization: 

This information will be transmitted 

to the CDC Security Office for approval. 

Visitors will be notified as soon as 

approval has been obtained. 

Public Review 

The external review of the draft 

document has been (1) developed in 

accordance with Office of Management 

and Budget (OMB) guidelines, (2) is 

consistent with NIOSH peer review 

practice, and (3) is meant to ensure that 

credible and appropriate science is 

reflected within the draft document. 

Dated: February 4, 2016. 

John Howard, 

Director, National Institute for Occupational 

Safety and Health, Centers for Disease Control 

and Prevention. 

[FR Doc. 2016–02650 Filed 2–9–16; 8:45 am] 

BILLING CODE 4163–19–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Disease, Disability, and Injury 

Prevention and Control Special 

Emphasis Panel (SEP): Initial Review 

In accordance with Section 10(a)(2) of 

the Federal Advisory Committee Act 

(Pub. L. 92–463), the Centers for Disease 

Control and Prevention (CDC) 

announces a meeting for the initial 

review of applications in response to 

Funding Opportunity Announcement 

(FOA) DP16–004, Childhood Obesity 

Research Demonstration 2.0. 

Time and Date: 10:00 a.m.–6:00 p.m., 

EST, March 15–16, 2016 (Closed). 

Place: Teleconference. 

Status: The meeting will be closed to 

the public in accordance with 

provisions set forth in Section 

552b(c)(4) and (6), Title 5 U.S.C., and 

the determination of the Director, 

Management Analysis and Services 

Office, CDC, pursuant to Public Law 92– 

463. 

Matters for Discussion: The meeting 

will include the initial review, 

discussion, and evaluation of 

applications received in response to 

FOA DP16–004, Childhood Obesity 

Research Demonstration 2.0. 


asabaliauskas on DSK9F6TC42PROD with NOTICES2
7124 Federal Register / Vol. 81, No. 27 / Wednesday, February 10, 2016 / Notices 

Contact Person for More Information: 

Jaya Raman, Ph.D., Scientific Review 

Officer, CDC, 4770 Buford Highway, 

Mailstop F80, Atlanta, Georgia 30341, 

Telephone: (770) 488–6511, kva5@

cdc.gov. 

The Director, Management Analysis 

and Services Office, has been delegated 

the authority to sign Federal Register 

notices pertaining to announcements of 

meetings and other committee 

management activities, for both the 

Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Catherine Ramadei, 

Acting Director, Management Analysis and 

Services Office, Centers for Disease Control 

and Prevention. 

[FR Doc. 2016–02582 Filed 2–9–16; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[Docket Number CDC–2016–0001; NIOSH– 

260–A] 

Draft Current Intelligence Bulletin: 

Health Effects of Occupational 

Exposure to Silver Nanomaterials; 

Notice of Public Meeting; Availability 

of Document for Comment; Extension 

of Comment Period 

AGENCY: National Institute for 

Occupational Safety and Health 

(NIOSH) of the Centers for Disease 

Control and Prevention (CDC), 

Department of Health and Human 

Services (HHS). 

ACTION: Notice and extension of 

comment period. 

SUMMARY: On January 21, 2016, the 

Director of the National Institute for 

Occupational Safety and Health 

(NIOSH) of the Centers for Disease 

Control and Prevention (CDC), 

published a notice in the Federal 

Register [81 FR 3425] announcing the 

availability of the following draft 

document for public comment entitled 

Draft Current Intelligence Bulletin: 

Health Effects of Occupational Exposure 

to Silver Nanomaterials. Written 

comments were to be received by March 

21, 2016. NIOSH is extending the public 

comment period until April 22, 2016. 

DATES: NIOSH is extending the 

comment period on the document 

published January 21, 2016 (81 FR 

3425). Electronic or written comments 

must be received by April 22, 2016. 

ADDRESSES: You may submit comments, 

identified by CDC–2016–0001 and 

docket number NIOSH–260–A, by any 

of the following methods: 

• Federal eRulemaking Portal: 

www.regulations.gov Follow the 

instructions for submitting comments. 

• Mail: National Institute for 

Occupational Safety and Health, NIOSH 

Docket Office, 1090 Tusculum Avenue, 

MS C–34, Cincinnati, Ohio 45226–1998. 

FOR FURTHER INFORMATION CONTACT: 

Charles Geraci, NIOSH, Education and 

Information Division, Nanotechnology 

Research Center, 1090 Tusculum 

Avenue, Cincinnati, Ohio 45226, 

telephone (513) 533–8339 (not a toll free 

number). 

Dated: February 3, 2016. 

John Howard, 

Director, National Institute for Occupational 

Safety and Health, Centers for Disease Control 

and Prevention. 

[FR Doc. 2016–02647 Filed 2–9–16; 8:45 am] 

BILLING CODE 4163–19–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Medicare & Medicaid 

Services 

[Document Identifier: CMS–276, CMS–1957, 

CMS–10599 and CMS–10600] 

Agency Information Collection 

Activities: Proposed Collection; 

Comment Request 

AGENCY: Centers for Medicare & 

Medicaid Services, HHS. 

ACTION: Notice. 

SUMMARY: The Centers for Medicare & 

Medicaid Services (CMS) is announcing 

an opportunity for the public to 

comment on CMS’ intention to collect 

information from the public. Under the 

Paperwork Reduction Act of 1995 (the 

PRA), federal agencies are required to 

publish notice in the Federal Register 

concerning each proposed collection of 

information (including each proposed 

extension or reinstatement of an existing 

collection of information) and to allow 

60 days for public comment on the 

proposed action. Interested persons are 

invited to send comments regarding our 

burden estimates or any other aspect of 

this collection of information, including 

any of the following subjects: (1) The 

necessity and utility of the proposed 

information collection for the proper 

performance of the agency’s functions; 

(2) the accuracy of the estimated 

burden; (3) ways to enhance the quality, 

utility, and clarity of the information to 

be collected; and (4) the use of 

automated collection techniques or 

other forms of information technology to 

minimize the information collection 

burden. 

DATES: Comments must be received by 

April 11, 2016: 

ADDRESSES: When commenting, please 

reference the document identifier or 

OMB control number. To be assured 

consideration, comments and 

recommendations must be submitted in 

any one of the following ways: 

1. Electronically. You may send your 

comments electronically to http://

www.regulations.gov. Follow the 

instructions for ‘‘Comment or 

Submission’’ or ‘‘More Search Options’’ 

to find the information collection 

document(s) that are accepting 

comments. 

2. By regular mail. You may mail 

written comments to the following 

address: CMS, Office of Strategic 

Operations and Regulatory Affairs, 

Division of Regulations Development, 

Attention: Document Identifier/OMB 

Control Number __, Room C4–26–05, 

7500 Security Boulevard, Baltimore, 

Maryland 21244–1850. 

To obtain copies of a supporting 

statement and any related forms for the 

proposed collection(s) summarized in 

this notice, you may make your request 

using one of following: 

1. Access CMS’ Web site address at 

http://www.cms.hhs.gov/

PaperworkReductionActof1995. 

2. Email your request, including your 

address, phone number, OMB number, 

and CMS document identifier, to 

Paperwork@cms.hhs.gov. 

3. Call the Reports Clearance Office at 

(410) 786–1326. 

FOR FURTHER INFORMATION CONTACT: 

Reports Clearance Office at (410) 786– 

1326. 

SUPPLEMENTARY INFORMATION: 

Contents 

This notice sets out a summary of the 

use and burden associated with the 

following information collections. More 

detailed information can be found in 

each collection’s supporting statement 

and associated materials (see 

ADDRESSES). 

CMS–276 Prepaid Health Plan Cost 

Report 

CMS–1957 Social Security Office (SSO) 

Report of State Buy-in Problem 

CMS–10599 Medicare Prior 

Authorization of Home Health 

Services Demonstration 

CMS–10600 Evaluation of the Medicare 

Patient Intravenous Immunoglobulin 

Demonstration 

Under the PRA (44 U.S.C. 3501– 

3520), federal agencies must obtain 

approval from the Office of Management 


asabaliauskas on DSK9F6TC42PROD with NOTICES2